Health
International trial of blood thinners for COVID-19 treatment begins – News-Medical.Net
These trials, known as ACTIV-4 Antithrombotics, are part of the three planned adaptive trials in this area of clinical research, included in the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) initiative. They are expected to yield new da…
A recent news release by the National Institutes of Health (NIH) announces the start of two Phase 3 clinical trials to explore blood thinners as treatments for COVID-19.
These trials, known as ACTIV-4 Antithrombotics, are part of the three planned adaptive trials in this area of clinical research, included in the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) initiative. They are expected to yield new data on the safety and efficacy of these drugs in the treatment of activ…
-
Business23 hours ago1 Australian stock you’ll probably kick yourself for not owning a decade from now
-
General12 hours agoToni Lamond, known for her roles in Annie Get Your Gun and My Fair Lady, dies aged 93
-
Business23 hours ago3 of the best ASX ETFs to build significant wealth
-
General22 hours agoUsman Khawaja describes Perth Stadium pitch for first Ashes Test as ‘piece of shit’